HOME >> MEDICINE >> NEWS
Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia

Orlando, FL, June 5, 2004 Two clinical studies presented at the American Diabetes Association's (ADA) Scientific Sessions showed that ACTOS (pioglitazone HCl) has favorable effects on dyslipidemia (low HDL-C levels, high triglycerides and high levels of small, dense LDL-C) and insulin resistance. Dyslipidemia and insulin resistance are two key components of the metabolic syndrome, which is often exhibited in patients with type 2 diabetes.

"When you put the pieces together, these separate findings are very exciting because they show that ACTOS therapy can provide benefits extending beyond improvements in glucose levels," said Mehmood Khan, M.D., F.A.C.E., senior vice president for medical and scientific affairs, Takeda Pharmaceuticals. "These studies showed that ACTOS can affect certain components of the metabolic syndrome, each of which must be managed when treating people with type 2 diabetes. We now have reason to believe that, when a physician prescribes ACTOS for type 2 diabetes, the patient may also benefit from a reduction of other risk factors."

Results of a pooled analysis of four separate, double-blind, randomized, multi-center trials conducted over the course of one year demonstrated that ACTOS has favorable effects on dyslipidemia in patients with type 2 diabetes. In each of the four trials, patients with poorly controlled type 2 diabetes were randomized to receive monotherapy consisting of ACTOS, metformin or a sulfonylurea (gliclazide), or a combination of ACTOS with these two agents.

Analysis of the data showed that, in addition to reducing hyperglycemia by addressing insulin resistance, ACTOS alone, or in combination with either metformin or the sulfonylurea, brought about a statistically significant decrease in serum triglycerides from baseline, and a statistically significant increase in HDL ("good") cholesterol, versus either of the other drugs alone or in combination with each other.

Additionally, statisticall
'"/>

Contact: Julio Cantre
julio.cantre@ketchum.com
646-935-4122
Ketchum
6-Jun-2004


Page: 1 2 3

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies demonstrate positive data in treatment of hepatitis C
8. Studies examine risk factors and potential consequences associated with prehypertension
9. Studies identify risk factors for colon cancer
10. Studies indicate healthy eating may affect cancer development, improve digestive system
11. Studies compare hysterectomy vs. other medical treatments for abnormal uterine bleeding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... 2020 , ... Representatives with Bay-Bay Water today announced that the company has launched ... company logo as part of the ongoing evolution of our company’s brand,” said Osmay Gonzalez, ... company is expanding its national reach. , “We have refreshed our logo to reflect who ...
(Date:2/20/2020)... ... , ... R3 Medical Training announced its next joint injection training courses scheduled ... injections for all large and small joints along with ultrasound needle guidance. , Performing ... opportunity is to perform injections in a supervised setting. R3 Medical Training's joint ...
(Date:2/19/2020)... MONROE, Conn. (PRWEB) , ... February 19, 2020 ... ... respected periodontists at Advanced Periodontics and Dental Implant Center of Connecticut, celebrate 30 ... all new patients with the same low fees that they charged in 1989, ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... quality and consistency of healthcare delivery, announced that it will participate in the ... in Orlando, Florida. BPM+ Health will engage healthcare professionals and other stakeholders at ...
(Date:2/16/2020)... ... 2020 , ... Canadian digital healthcare portal Ask The Doctor has ... about the Coronavirus. , "It is our duty and it is our responsibility to ... said Prakash Chand, CEO of Ask The Doctor. , Doctors and nurses around the ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... ... 2020 , ... NeoTract, a wholly owned subsidiary of Teleflex ... announced that Jayant Uberoi, MD, Chesapeake Urology in Baltimore MD, has been designated ... achieved a high level of training and experience with the UroLift® System and ...
(Date:2/19/2020)... ... February 19, 2020 , ... Aspire Regenerative, a leader ... with Cortex Wellness Pharmacy for a free weight-loss event on March 1, 2020. It ... Ave., #100, La Jolla, CA, 92037. , During the event, physicians and pharmacists will ...
(Date:2/19/2020)... ... February 19, 2020 , ... The Team Type 1 Foundation, ... medicine for everyone affected by diabetes, announced a partnership with VeloCity, a fundraising ride ... third annual VeloCity event takes place on May 2nd and begins on the Mercedes-Benz ...
Breaking Medicine Technology:
Cached News: